New York - The newest systemic antibiotics aren't always the best, especially when their overuse creates concerns for drug resistance.
Lebrikizumab Demonstrates Promising Results in Atopic Dermatitis
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Highlights from AAD 2023
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
New Technology Could Allow Us to Rethink Alopecia Scores
Upadacitinib Advances to Phase 3 Clinical Trials in Systemic Lupus Erythematosus